Roivios Announces Promising Outcomes from Groundbreaking JuxtaFlow Renal Device Trial Roivios has reported encouraging findings from the first human trial of its JuxtaFlow Renal Assist Device, aimed at enhancing kidney health.

Roivios Announces Promising Outcomes from Groundbreaking JuxtaFlow Renal Device Trial #None #Health #Roivios #JuxtaFlow

Innovative Partnership between Roivios and Caresyntax Aims to Transform Renal Care with Data Insights Roivios and Caresyntax have teamed up to enhance kidney care using data-driven insights, aiming to improve patient outcomes and reduce costs.

Innovative Partnership between Roivios and Caresyntax Aims to Transform Renal Care with Data Insights #United_States #San_Francisco #Roivios #Caresyntax #JuxtaFlow

FDA Approval for Pivotal Trial of Innovative JuxtaFlow® Renal Assist Device Marks Significant Milestone in Kidney Health Roivios announces FDA IDE approval for the pivotal trial of its JuxtaFlow Renal Assist Device, aimed at improving outcomes in kidney health for cardiac surgery patients.

FDA Approval for Pivotal Trial of Innovative JuxtaFlow® Renal Assist Device Marks Significant Milestone in Kidney Health #USA #FDA_Approval #Nassau #JuxtaFlow_RAD #Roivios